IDXX

Idexx Laboratories Stock Analysis

AI Rating

Neutral
  • Quality9/10
  • Growth 6/10
  • Value 1/10
Idexx Laboratories sales and earnings growth
IDXX Growth
Good
  • Revenue Y/Y 13.08%
  • EPS Y/Y 25.46%
  • FCF Y/Y 27.72%
Idexx Laboratories gross and profit margin trends
IDXX Profitability
Great
  • Gross margin 62.10%
  • EPS margin 24.60%
  • ROIC 5Y 47.88%
Idexx Laboratories net debt vs free cash flow
IDXX Risk
Great
  • Debt / Equity 0.7
  • Debt / FCF 0.8
  • Interest coverage 36.2

Idexx Laboratories stock volatility is in-line with the overall market. We give it a Great risk rating.

↗ More Diagnostics & Research stocks